Proteins and Peptides
24 March 2018
OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes22 March 2018
BioArctic Receives Regulatory Approval in Norway for a Clinical Study in Patients With Complete Spinal Cord Injury19 March 2018
Semaglutide injection phase 2 data presented at ENDO demonstrated significant weight loss in adults with obesity13 March 2018
Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection12 March 2018
Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura10 March 2018
AM-Pharma Announces Phase II Study Results of recAP in Sepsis-Associated Acute Kidney Injury6 March 2018
Lyric Completes Enrollment in Phase 2 PROMOTE Study of LP101 (Ulimorelin) in Enteral Feeding Intolerance28 February 2018
U.S. FDA Accepts Shire’s Biologics License Application for Calaspargase Pegol (Cal-PEG) for Acute Lymphoblastic Leukemia (ALL)27 February 2018
Novo Nordisk files for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A25 February 2018
Kineret® (anakinra) Receives a Positive Opinion from CHMP for the Treatment of Still’s Disease22 February 2018
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22 February 2018
Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide22 February 2018
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke22 February 2018
Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy21 February 2018
Orano Med and RadioMedix announce dosing of first patients in AlphaMedix™ Phase 1 clinical trial16 February 2018
Xeris Pharmaceuticals Achieves Phase 3 Milestones of its Ready-to-Use Glucagon Rescue Pen for the Treatment of Severe HypoglycemiaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports